Viewing Study NCT07340827

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-06-11 @ 12:56 AM
Study NCT ID: NCT07340827
Status: RECRUITING
Last Update Posted: 2026-03-18
First Post: 2026-01-06
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Infertility View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gonadotropins, infertility, prefilled pen View